The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2011Regulated GDNF Gene Therapy: a Novel Regulatory System Based on Protein Degradation
Objective/Rationale:
Gene therapy may offer effective treatments to patients. Delivering genes to cells in the body has the potential of letting the patient’s cells treat themselves. In the case of... -
MJFF Research Grant, 2011Global Estimates for the Role of LRRK2 Variation in Parkinson's Disease Susceptibility
Promising Outcomes of Original Grant:
Our original goal was to resolve the role of known LRRK2 coding variants in susceptibility to Parkinson’s disease. Our studies have nominated risk factors for... -
Research Grant, 2011Targeting Glia in PD with Novel Anti-inflammatory Therapeutics
Objective/Rationale:
Loss of dopamine-producing neurons in Parkinson’s disease (PD) is accompanied by inflammation in surrounding support cells, called glial cells. This inflammatory state in glial... -
LRRK2 Target Engagement Ligand, 2011Development of LRRK2 Target Engagement Ligands
Objective/Rationale:
The overall objective of this project is to generate the data necessary to ultimately identify a small organic molecule capable of binding to a sub-domain of the LRRK2 protein... -
MJFF Research Grant, 2011Development of Functional Imaging for CB-1 and 5-HT1a in PD Participants with Dyskinesia
Objective/Rationale:
The goal of this proposal is to develop two imaging tests, [18F]MK-9470 and [18F]MPPF, to assess the function of two receptors (cannabinoid – CB-1 and serotonin receptor – 5-HT1a... -
MJFF Research Grant, 2011Evaluation of LRRK2-derived Bioportides as Functional Protein Modulators and Potential Therapeutics
Objective/Rationale:
The therapeutic actions of most existing drugs are the result of their binding to molecules known as proteins that are associated with certain cells of the human body. However...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.